O	O	O	0	3	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	4	8	role	role	I-NP	NN	O	0	ROOT	O
O	O	O	9	11	of	of	B-PP	IN	O	2	NMOD	O
T1	B-Protein	B-Protein	12	15	p16	p16	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	O	16	18	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	19	22	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	23	26	E2F	E2F	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	26	27	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	O	27	36	dependent	dependent	I-NP	JJ	O	12	NMOD	O
T2	B-Protein	B-Protein	37	46	thymidine	thymidine	I-NP	NN	O	12	NMOD	O
T2	I-Protein	I-Protein	47	53	kinase	kinase	I-NP	NN	O	12	NMOD	O
O	O	O	54	64	regulation	regulation	I-NP	NN	O	5	PMOD	O
O	O	O	64	65	.	.	O	.	O	2	P	O

O	O	O	67	70	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	71	75	role	role	I-NP	NN	O	34	SUB	O
O	O	O	76	78	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	79	90	alterations	alteration	B-NP	NNS	O	3	PMOD	O
O	O	O	91	93	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	94	97	the	the	B-NP	DT	O	10	NMOD	O
T3	B-Protein	B-Protein	98	102	MTS1	MTS1	I-NP	NN	B-DNA	10	NMOD	B-DNA
T25	B-Entity	B-Entity	103	108	tumor	tumor	I-NP	NN	I-DNA	10	NMOD	I-DNA
T25	I-Entity	I-Entity	109	119	suppressor	suppressor	I-NP	NN	I-DNA	10	NMOD	I-DNA
T25	I-Entity	I-Entity	120	124	gene	gene	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	O	125	127	on	on	B-PP	IN	O	4	NMOD	O
O	O	O	128	138	chromosome	chromosome	B-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	O	139	143	9p21	9p21	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	143	144	,	,	O	,	O	4	P	O
O	O	O	145	150	which	which	B-NP	WDT	O	4	NMOD	O
O	O	O	151	158	encodes	encode	B-VP	VBZ	O	15	SBAR	O
T4	B-Protein	B-Protein	159	162	p16	p16	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	162	163	,	,	O	,	O	20	P	O
O	O	O	164	167	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	168	177	inhibitor	inhibitor	I-NP	NN	O	16	OBJ	O
O	O	O	178	180	of	of	B-PP	IN	O	20	NMOD	O
T5	B-Protein	B-Protein	181	187	cyclin	cyclin	B-NP	NN	B-protein	30	NMOD	B-protein
T5	I-Protein	I-Protein	187	188	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T5	I-Protein	I-Protein	188	197	dependent	dependent	I-NP	JJ	I-protein	30	NMOD	I-protein
T5	I-Protein	I-Protein	197	198	-	-	I-NP	HYPH	I-protein	30	NMOD	I-protein
T5	I-Protein	I-Protein	198	204	kinase	kinase	I-NP	NN	I-protein	30	NMOD	I-protein
T5	I-Protein	I-Protein	204	205	-	-	B-NP	HYPH	O	30	NMOD	O
T5	I-Protein	I-Protein	205	206	4	4	I-NP	CD	O	30	NMOD	O
O	O	O	207	210	and	and	I-NP	CC	O	30	NMOD	O
T6	B-Protein	B-Protein	211	212	6	6	I-NP	CD	O	21	PMOD	O
O	O	O	212	213	,	,	O	,	O	4	P	O
O	O	O	214	216	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	217	230	tumorigenesis	tumorigenesis	B-NP	NN	O	32	PMOD	O
O	O	O	231	233	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	234	237	not	not	O	RB	O	34	VMOD	O
O	O	O	238	241	yet	yet	B-ADJP	RB	O	34	VMOD	O
O	O	O	242	247	clear	clear	I-ADJP	JJ	O	34	PRD	O
O	O	O	247	248	.	.	O	.	O	34	P	O

O	O	O	249	264	Phosphorylation	Phosphorylation	B-NP	NN	O	14	SUB	O
O	O	O	265	267	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	268	271	the	the	B-NP	DT	O	5	NMOD	O
T7	B-Protein	B-Protein	272	286	retinoblastoma	retinoblastoma	I-NP	NN	B-protein	5	NMOD	B-protein
T7	I-Protein	I-Protein	287	294	protein	protein	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	295	297	by	by	B-PP	IN	O	1	NMOD	O
T8	B-Protein	B-Protein	298	304	cyclin	cyclin	B-NP	NN	B-protein	10	NMOD	B-protein
T8	I-Protein	I-Protein	304	305	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T8	I-Protein	I-Protein	305	314	dependent	dependent	I-NP	JJ	I-protein	10	NMOD	I-protein
T8	I-Protein	I-Protein	315	322	kinases	kinase	I-NP	NNS	I-protein	6	PMOD	I-protein
T8	I-Protein	I-Protein	323	324	4	4	B-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	325	328	and	and	I-NP	CC	I-protein	10	NMOD	I-protein
T9	B-Protein	B-Protein	329	330	6	6	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	331	339	prevents	prevent	B-VP	VBZ	O	0	ROOT	O
O	O	O	340	343	its	its	B-NP	PRP$	O	16	NMOD	O
O	O	O	344	355	interaction	interaction	I-NP	NN	O	14	OBJ	O
O	O	O	356	360	with	with	B-PP	IN	O	16	NMOD	O
O	O	O	361	364	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	365	378	transcription	transcription	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	379	385	factor	factor	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	386	389	E2F	E2F	I-NP	NN	B-protein	17	PMOD	B-protein
O	O	O	389	390	,	,	O	,	O	21	P	O
O	O	O	391	396	which	which	B-NP	WDT	O	21	NMOD	O
O	O	O	397	409	subsequently	subsequently	B-ADVP	RB	O	25	VMOD	O
O	O	O	410	418	promotes	promote	B-VP	VBZ	O	23	SBAR	O
O	O	O	419	422	the	the	B-NP	DT	O	27	NMOD	O
O	O	O	423	433	expression	expression	I-NP	NN	O	25	OBJ	O
O	O	O	434	436	of	of	B-PP	IN	O	27	NMOD	O
T26	B-Entity	B-Entity	437	438	S	S	B-NP	NN	B-DNA	32	NMOD	B-DNA
T26	I-Entity	I-Entity	439	444	phase	phase	I-NP	NN	I-DNA	32	NMOD	I-DNA
T26	I-Entity	I-Entity	445	454	regulated	regulated	I-NP	JJ	I-DNA	32	NMOD	I-DNA
T26	I-Entity	I-Entity	455	460	genes	gene	I-NP	NNS	I-DNA	28	PMOD	I-DNA
O	O	O	460	461	,	,	O	,	O	32	P	O
O	O	O	462	466	such	such	B-PP	JJ	O	35	PMOD	O
O	O	O	467	469	as	as	I-PP	IN	O	32	NMOD	O
T10	B-Protein	B-Protein	470	479	thymidine	thymidine	B-NP	NN	B-protein	37	NMOD	B-protein
T10	I-Protein	I-Protein	480	486	kinase	kinase	I-NP	NN	I-protein	35	PMOD	I-protein
O	O	O	486	487	.	.	O	.	O	14	P	O

O	O	O	488	496	Although	Although	B-SBAR	IN	O	14	VMOD	O
O	O	O	497	498	a	a	B-NP	DT	O	3	NMOD	O
O	O	O	499	503	role	role	I-NP	NN	O	9	SUB	O
O	O	O	504	506	of	of	B-PP	IN	O	3	NMOD	O
T11	B-Protein	B-Protein	507	510	p16	p16	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	O	511	513	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	514	518	this	this	B-NP	DT	O	8	NMOD	O
O	O	O	519	529	regulation	regulation	I-NP	NN	O	6	PMOD	O
O	O	O	530	533	has	have	B-VP	VBZ	O	1	SBAR	O
O	O	O	534	538	been	be	I-VP	VBN	O	9	VC	O
O	O	O	539	547	presumed	presume	I-VP	VBN	O	10	VC	O
O	O	O	547	548	,	,	O	,	O	14	P	O
O	O	O	549	554	there	there	B-NP	EX	O	14	SUB	O
O	O	O	555	557	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	558	560	no	no	B-NP	DT	O	16	NMOD	O
O	O	O	561	566	proof	proof	I-NP	NN	O	14	PRD	O
O	O	O	567	569	so	so	B-ADVP	RB	O	16	NMOD	O
O	O	O	570	573	far	far	I-ADVP	RB	O	17	AMOD	O
O	O	O	574	578	that	that	B-SBAR	IN	O	16	NMOD	O
O	O	O	579	583	loss	loss	B-NP	NN	O	27	SUB	O
O	O	O	584	586	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	587	591	this	this	B-NP	DT	O	25	NMOD	O
T27	B-Entity	B-Entity	592	597	tumor	tumor	I-NP	NN	B-DNA	25	NMOD	B-DNA
T27	I-Entity	I-Entity	598	608	suppressor	suppressor	I-NP	NN	I-DNA	25	NMOD	I-DNA
T27	I-Entity	I-Entity	609	613	gene	gene	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	O	614	620	really	really	B-ADVP	RB	O	27	VMOD	O
O	O	O	621	628	affects	affect	B-VP	VBZ	O	19	SBAR	O
O	O	O	629	632	E2F	E2F	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	O	632	633	-	-	B-NP	HYPH	O	31	P	O
O	O	O	633	641	mediated	mediate	I-NP	VBN	O	31	NMOD	O
O	O	O	642	653	regulations	regulation	I-NP	NNS	O	27	OBJ	O
O	O	O	653	654	.	.	O	.	O	14	P	O

O	O	O	655	657	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	658	670	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	O	671	674	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	675	685	regulation	regulation	I-NP	NN	O	32	NMOD	O
O	O	O	686	688	of	of	B-PP	IN	O	4	NMOD	O
T12	B-Protein	B-Protein	689	698	thymidine	thymidine	B-NP	NN	B-protein	7	NMOD	B-protein
T12	I-Protein	I-Protein	699	705	kinase	kinase	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	706	708	in	in	B-PP	IN	O	4	NMOD	O
T13	B-Protein	B-Protein	709	727	phytohemagglutinin	phytohemagglutinin	B-NP	NN	B-protein	8	PMOD	B-protein
O	O	O	727	728	-	-	O	HYPH	O	9	P	O
O	O	O	728	738	stimulated	stimulate	B-NP	VBN	O	14	NMOD	O
O	O	O	739	745	normal	normal	I-NP	JJ	O	14	NMOD	O
O	O	O	746	751	human	human	I-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	752	763	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	764	767	and	and	B-PP	CC	O	8	PMOD	O
O	O	O	768	770	in	in	B-PP	IN	O	8	PMOD	O
O	O	O	771	774	the	the	B-NP	DT	O	26	NMOD	O
T14	B-Protein	B-Protein	775	778	p16	p16	I-NP	NN	B-cell_line	26	NMOD	B-cell_line
O	O	O	778	779	-	-	B-NP	HYPH	I-cell_line	26	NMOD	I-cell_line
O	O	O	779	787	negative	negative	I-NP	JJ	I-cell_line	26	NMOD	I-cell_line
O	O	O	788	793	human	human	I-NP	JJ	I-cell_line	26	NMOD	I-cell_line
O	O	O	794	799	acute	acute	I-NP	JJ	I-cell_line	26	NMOD	I-cell_line
O	O	O	800	813	lymphoblastic	lymphoblastic	I-NP	JJ	I-cell_line	26	NMOD	I-cell_line
O	O	O	814	822	leukemia	leukemia	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	O	823	827	cell	cell	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	O	828	833	lines	line	I-NP	NNS	I-cell_line	16	PMOD	I-cell_line
O	O	O	833	834	,	,	O	,	O	32	P	O
O	O	O	835	839	MOLT	MOLT	B-NP	NN	B-cell_line	32	NMOD	B-cell_line
O	O	O	839	840	-	-	I-NP	HYPH	I-cell_line	32	NMOD	I-cell_line
O	O	O	840	841	4	4	I-NP	CD	I-cell_line	32	NMOD	I-cell_line
O	O	O	842	845	and	and	I-NP	CC	O	32	NMOD	O
O	O	O	846	849	CEM	CEM	I-NP	NN	B-cell_line	2	OBJ	B-cell_line
O	O	O	849	850	.	.	O	.	O	2	P	O

O	O	O	851	859	Compared	Compare	B-PP	VBN	O	12	VMOD	O
O	O	O	860	862	to	to	B-PP	TO	O	1	PMOD	O
O	O	O	863	869	normal	normal	B-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	O	870	881	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	O	881	882	,	,	O	,	O	12	P	O
O	O	O	883	887	MOLT	MOLT	B-NP	NN	B-cell_line	11	NMOD	B-cell_line
O	O	O	887	888	-	-	B-NP	HYPH	I-cell_line	11	NMOD	I-cell_line
O	O	O	888	889	4	4	I-NP	CD	I-cell_line	11	NMOD	I-cell_line
O	O	O	890	893	and	and	I-NP	CC	O	11	NMOD	O
O	O	O	894	897	CEM	CEM	I-NP	NN	B-cell_line	11	NMOD	B-cell_line
O	O	O	898	903	cells	cell	I-NP	NNS	I-cell_line	12	SUB	I-cell_line
O	O	O	904	913	exhibited	exhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	914	916	an	an	B-NP	DT	O	17	NMOD	O
O	O	O	917	924	altered	altered	I-NP	JJ	O	17	NMOD	O
O	O	O	925	929	cell	cell	I-NP	NN	O	17	NMOD	O
O	O	O	930	935	cycle	cycle	I-NP	NN	O	17	NMOD	O
O	O	O	936	946	regulation	regulation	I-NP	NN	O	12	OBJ	O
O	O	O	947	949	of	of	B-PP	IN	O	17	NMOD	O
T15	B-Protein	B-Protein	950	959	thymidine	thymidine	B-NP	NN	B-protein	20	NMOD	B-protein
T15	I-Protein	I-Protein	960	966	kinase	kinase	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	966	967	,	,	O	,	O	26	P	O
O	O	O	968	969	a	a	B-NP	DT	O	26	NMOD	O
O	O	O	970	974	much	much	I-NP	RB	O	25	AMOD	O
O	O	O	975	981	higher	high	I-NP	JJR	O	25	AMOD	O
O	O	O	982	995	intracellular	intracellular	I-NP	JJ	O	26	NMOD	O
O	O	O	996	1004	activity	activity	I-NP	NN	O	18	PMOD	O
O	O	O	1005	1007	of	of	B-PP	IN	O	26	NMOD	O
O	O	O	1008	1012	this	this	B-NP	DT	O	29	NMOD	O
O	O	O	1013	1019	enzyme	enzyme	I-NP	NN	B-protein	27	PMOD	B-protein
O	O	O	1019	1020	,	,	O	,	O	36	P	O
O	O	O	1021	1024	and	and	O	CC	O	36	NMOD	O
O	O	O	1025	1031	higher	high	B-NP	JJR	O	36	NMOD	O
T16	B-Protein	B-Protein	1032	1041	thymidine	thymidine	I-NP	NN	B-RNA	36	NMOD	B-RNA
T16	I-Protein	I-Protein	1042	1048	kinase	kinase	I-NP	NN	I-RNA	36	NMOD	I-RNA
O	O	O	1049	1053	mRNA	mRNA	I-NP	NN	I-RNA	36	NMOD	I-RNA
O	O	O	1054	1064	expression	expression	I-NP	NN	O	12	VMOD	O
O	O	O	1064	1065	.	.	O	.	O	12	P	O

O	O	O	1066	1075	Transient	Transient	B-NP	JJ	O	2	NMOD	O
O	O	O	1076	1086	expression	expression	I-NP	NN	O	9	SUB	O
O	O	O	1087	1089	of	of	B-PP	IN	O	2	NMOD	O
T17	B-Protein	B-Protein	1090	1093	p16	p16	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	O	1094	1096	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	1097	1103	normal	normal	B-NP	JJ	B-cell_type	8	NMOD	B-cell_type
O	O	O	1104	1109	human	human	I-NP	JJ	I-cell_type	8	NMOD	I-cell_type
O	O	O	1110	1121	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	O	1122	1128	caused	cause	B-VP	VBD	O	0	ROOT	O
O	O	O	1129	1135	arrest	arrest	B-NP	NN	O	9	OBJ	O
O	O	O	1136	1138	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	1139	1141	G1	G1	B-NP	NN	O	11	PMOD	O
O	O	O	1141	1142	,	,	O	,	O	9	P	O
O	O	O	1143	1146	but	but	O	CC	O	9	VMOD	O
O	O	O	1147	1150	was	be	B-VP	VBD	O	9	VMOD	O
O	O	O	1151	1158	without	without	B-PP	IN	O	15	PRD	O
O	O	O	1159	1165	effect	effect	B-NP	NN	O	16	PMOD	O
O	O	O	1166	1168	on	on	B-PP	IN	O	17	NMOD	O
O	O	O	1169	1172	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	1173	1177	cell	cell	I-NP	NN	O	21	NMOD	O
O	O	O	1178	1184	growth	growth	I-NP	NN	O	18	PMOD	O
O	O	O	1185	1187	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	1188	1192	MOLT	MOLT	B-NP	NN	B-cell_line	28	NMOD	B-cell_line
O	O	O	1192	1193	-	-	B-NP	HYPH	I-cell_line	28	NMOD	I-cell_line
O	O	O	1193	1194	4	4	I-NP	CD	I-cell_line	28	NMOD	I-cell_line
O	O	O	1195	1198	and	and	I-NP	CC	I-cell_line	28	NMOD	I-cell_line
O	O	O	1199	1202	CEM	CEM	I-NP	NN	I-cell_line	28	NMOD	I-cell_line
O	O	O	1203	1208	cells	cell	I-NP	NNS	I-cell_line	22	PMOD	I-cell_line
O	O	O	1208	1209	,	,	O	,	O	9	P	O
O	O	O	1210	1218	although	although	B-SBAR	IN	O	9	VMOD	O
O	O	O	1219	1222	all	all	B-NP	DT	O	34	SUB	O
O	O	O	1223	1225	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	1226	1230	them	them	B-NP	PRP	O	32	PMOD	O
O	O	O	1231	1238	express	express	B-VP	VBP	O	30	SBAR	O
O	O	O	1239	1249	functional	functional	B-NP	JJ	O	34	OBJ	O
T18	B-Protein	B-Protein	1250	1264	retinoblastoma	retinoblastoma	I-NP	NN	B-protein	37	NMOD	B-protein
T18	I-Protein	I-Protein	1265	1272	protein	protein	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	O	1272	1273	.	.	O	.	O	9	P	O

O	O	O	1274	1286	Nevertheless	Nevertheless	B-ADVP	RB	O	13	VMOD	O
O	O	O	1286	1287	,	,	O	,	O	13	P	O
O	O	O	1288	1290	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	1291	1294	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1295	1298	two	two	I-NP	CD	O	8	NMOD	O
O	O	O	1299	1307	leukemia	leukemia	I-NP	NN	B-cell_line	8	NMOD	B-cell_line
O	O	O	1308	1312	cell	cell	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	O	1313	1318	lines	line	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	O	1319	1328	transient	transient	B-NP	JJ	O	10	NMOD	O
O	O	O	1329	1343	overexpression	overexpression	I-NP	NN	O	13	SUB	O
O	O	O	1344	1346	of	of	B-PP	IN	O	10	NMOD	O
T19	B-Protein	B-Protein	1347	1350	p16	p16	B-NP	NN	B-protein	11	PMOD	B-protein
O	O	O	1351	1364	reestablished	reestablish	B-VP	VBD	O	0	ROOT	O
O	O	O	1365	1368	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1369	1375	normal	normal	I-NP	JJ	O	16	NMOD	O
O	O	O	1376	1386	regulation	regulation	I-NP	NN	O	13	OBJ	O
O	O	O	1387	1389	of	of	B-PP	IN	O	16	NMOD	O
T20	B-Protein	B-Protein	1390	1399	thymidine	thymidine	B-NP	NN	B-protein	19	NMOD	B-protein
T20	I-Protein	I-Protein	1400	1406	kinase	kinase	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	1406	1407	,	,	O	,	O	16	P	O
O	O	O	1408	1418	paralleled	parallel	B-VP	VBN	O	16	NMOD	O
O	O	O	1419	1421	by	by	B-PP	IN	O	21	VMOD	O
O	O	O	1422	1424	an	an	B-NP	DT	O	24	NMOD	O
O	O	O	1425	1433	increase	increase	I-NP	NN	O	33	NMOD	O
O	O	O	1434	1436	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	1437	1440	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	1441	1460	underphosphorylated	underphosphorylated	I-NP	JJ	O	28	NMOD	O
O	O	O	1461	1465	form	form	I-NP	NN	O	25	PMOD	O
O	O	O	1466	1468	of	of	B-PP	IN	O	28	NMOD	O
T21	B-Protein	B-Protein	1469	1483	retinoblastoma	retinoblastoma	B-NP	NN	B-protein	31	NMOD	B-protein
T21	I-Protein	I-Protein	1484	1491	protein	protein	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	O	1492	1495	and	and	O	CC	O	33	NMOD	O
O	O	O	1496	1504	decrease	decrease	B-NP	NN	O	22	PMOD	O
O	O	O	1505	1507	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	1508	1512	free	free	B-NP	JJ	O	34	PMOD	O
O	O	O	1513	1516	E2F	E2F	I-NP	NN	B-protein	35	NMOD	B-protein
O	O	O	1517	1522	bound	bind	B-VP	VBD	O	35	NMOD	O
O	O	O	1523	1525	to	to	B-PP	TO	O	37	VMOD	O
T28	B-Entity	B-Entity	1526	1529	its	its	B-NP	PRP$	O	40	NMOD	O
T28	I-Entity	I-Entity	1530	1535	motif	motif	I-NP	NN	O	38	PMOD	O
O	O	O	1536	1538	in	in	B-PP	IN	O	40	NMOD	O
O	O	O	1539	1542	the	the	B-NP	DT	O	45	NMOD	O
T22	B-Protein	B-Protein	1543	1552	thymidine	thymidine	I-NP	NN	B-DNA	45	NMOD	B-DNA
T22	I-Protein	I-Protein	1553	1559	kinase	kinase	I-NP	NN	I-DNA	45	NMOD	I-DNA
T29	B-Entity	B-Entity	1560	1568	promoter	promoter	I-NP	NN	I-DNA	41	PMOD	I-DNA
O	O	O	1568	1569	.	.	O	.	O	13	P	O

O	O	O	1570	1572	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	1573	1584	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	1585	1589	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	1590	1594	loss	loss	B-NP	NN	O	7	SUB	O
O	O	O	1595	1597	of	of	B-PP	IN	O	4	NMOD	O
T23	B-Protein	B-Protein	1598	1601	p16	p16	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	O	1602	1608	causes	cause	B-VP	VBZ	O	3	SBAR	O
O	O	O	1609	1621	upregulation	upregulation	B-NP	NN	O	7	OBJ	O
O	O	O	1622	1624	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1625	1629	this	this	B-NP	DT	O	13	NMOD	O
O	O	O	1630	1633	DNA	DNA	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1634	1643	precursor	precursor	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1644	1651	pathway	pathway	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	1652	1658	enzyme	enzyme	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	O	1659	1662	via	via	B-PP	IN	O	8	NMOD	O
O	O	O	1663	1673	activation	activation	B-NP	NN	O	15	PMOD	O
O	O	O	1674	1676	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1677	1680	E2F	E2F	B-NP	NN	B-protein	17	PMOD	B-protein
O	O	O	1681	1683	by	by	B-PP	IN	O	16	NMOD	O
O	O	O	1684	1685	a	a	B-NP	DT	O	21	NMOD	O
O	O	O	1686	1695	mechanism	mechanism	I-NP	NN	O	19	PMOD	O
O	O	O	1696	1705	involving	involve	B-VP	VBG	O	21	NMOD	O
T24	B-Protein	B-Protein	1706	1720	retinoblastoma	retinoblastoma	B-NP	NN	B-protein	24	NMOD	B-protein
T24	I-Protein	I-Protein	1721	1728	protein	protein	I-NP	NN	I-protein	22	OBJ	I-protein
O	O	O	1728	1729	.	.	O	.	O	2	P	O
